Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2324.40Today’s High
2434.0052W low
1246.8052W High
2540.00Open Price
2388.40Prev. Close
2124.3000Volume
374503.00Value
904256218.65Fundamentals
Market Cap Cr
30403.20
Price to Earnings
37.30
Price to Book Value
8.50
Dividend Yield
2.10
PE to Growth
1.00
Op Revenue TTM Cr
4208.71
Net Profit TTM Cr
816.17
Cash From Operating Activity Cr
785.07
Return on Equity %
22.87
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
06 May, 2024
25.8
Week
19.4
Month
30.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2391.00
PIVOT
First Resistance
2457.55
Second Resistance
2500.55
Third Resistance
2567.10
First Support
2348.00
Second Support
2281.45
Third Support
2238.45
Relative Strength Index
77.51
Money Flow Index
86.06
MACD
44.11
MACD Signal
14.06
Average True Range
86.29
Average Directional Index
32.84
Rate of Change (21)
6.34
Rate of Change (125)
32.12
Commodity Channel Index
216.2
Williams %R
-25.7
BETA
1 Month
-0.6
3 Month
-0.35
1 Year
-0.13
3 Year
0
PRICE CHANGE ANALYSIS
↑ 10.08%
1 Week
Low
High
2190
2540
↑ 10.68%
1 Month
Low
High
2051.6
2540
↑ 11.51%
3 Months
Low
High
1998.35
2540
↑ 32.25%
6 Months
Low
High
1783.5
2540
↑ 85.96%
1 Year
Low
High
1246.75
2540
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 959.75 | 1099.02 | 997.34 | 1046.04 | 885.61 | 905.40 | 915.60 | 885.71 | 794.05 | 836.48 | 876.12 | |
| Operating Expenses Qtr | 698.92 | 758.11 | 671.53 | 737.68 | 704.33 | 715.48 | 676.50 | 663.98 | 578.48 | 570.71 | 590.86 | |
| Operating Profit Qtr | 227.15 | 327.18 | 273.65 | 276.90 | 144.53 | 159.41 | 160.73 | 186.31 | 187.15 | 237.87 | 232.85 | |
| EBIDT Qtr Cr | 260.83 | 340.91 | 325.81 | 308.36 | 181.28 | 189.92 | 239.10 | 221.73 | 215.57 | 265.77 | 285.26 | |
| Depreciation Qtr | 33.47 | 33.41 | 33.04 | 32.24 | 32.11 | 32.29 | 31.80 | 30.75 | 30.09 | 30.71 | 30.40 | |
| Net Profit Qtr | 162.69 | 220.15 | 212.36 | 212.04 | 117.21 | 123.96 | 167.18 | 150.37 | 134.84 | 194.71 | 196.85 | |
| Basic EPS Qtr | 12.92 | 17.48 | 16.87 | 16.84 | 9.15 | 9.67 | 13.05 | 11.74 | 15.79 | 22.50 | 22.75 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 4087.60 | 3544.02 | 3280.37 | 2822.16 | 2380.62 | |
| Operating Expenses Annual Cr | 2851.69 | 2711.99 | 2249.75 | 1801.68 | 1663.64 | |
| Operating Profit Annual | 1119.43 | 699.28 | 890.89 | 916.91 | 532.78 | |
| Operating Profit Margin Annual % | 27.39 | 19.73 | 27.16 | 32.49 | 22.38 | |
| Total Expenses Annual Cr | 2990.65 | 2844.17 | 2379.83 | 1920.07 | 1764.03 | |
| EBIDT Annual Cr | 1235.91 | 832.03 | 1030.62 | 1020.48 | 716.98 | |
| EBIDT Annual margin % | 30.24 | 23.48 | 31.42 | 36.16 | 30.12 | |
| Depreciation | 132.16 | 126.95 | 120.96 | 111.49 | 91.29 | |
| PAT Before ExtraOrdinary Items Annual Cr | 807.24 | 558.72 | 719.86 | 675.64 | 441.13 | |
| Net Profit Annual | 807.24 | 558.72 | 719.86 | 675.64 | 441.13 | |
| Basic EPS Annual | 64.11 | 43.61 | 83.28 | 77.59 | 50.55 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3413.57 | 3246.45 | 3169.18 | 2884.98 | 2461.30 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 174.17 | 150.50 | 141.61 | 130.99 | 112.91 | |
| Total Current Liabilities Annual Cr | 629.70 | 907.84 | 469.70 | 516.09 | 474.94 | |
| Total Capital Plus Liabilities Annual Cr | 4217.44 | 4304.79 | 3780.49 | 3532.06 | 3049.15 | |
| Fixed Assets Annual | 1721.34 | 1693.48 | 1645.18 | 1626.98 | 1580.38 | |
| Total Non Current Assets Annual | 1775.77 | 1753.60 | 1723.48 | 1695.85 | 1634.07 | |
| Total Current Assets Annual | 2441.67 | 2551.19 | 2057.01 | 1836.21 | 1415.08 | |
| Total Assets Annual | 4217.44 | 4304.79 | 3780.49 | 3532.06 | 3049.15 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 91.52 | 76.44 | 168.98 | 182.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 735.35 | 736.29 | 542.34 | 466.99 | 300.88 | |
| Cash from Investing Activity Annual | 105.02 | -501.31 | -66.04 | -162.68 | -115.91 | |
| Cash from Financing Annual Activity | -1047.70 | -105.12 | -457.30 | -268.90 | -134.00 | |
| Net Cash Flow Annual | - | 129.86 | 19.00 | 35.41 | 50.97 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 270.17 | 256.94 | 369.15 | 331.80 | 280.65 | |
| ROE Annual % | 23.64 | 17.21 | 22.71 | 23.41 | 17.92 | |
| ROCE Annual % | 30.76 | 20.75 | 27.47 | 30.13 | 24.30 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 31.12 | 24.39 | 32.81 | 37.53 | 32.64 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1089.58 | 1118.74 | 1049.77 | 1052.79 | 918.67 | 1006.70 | 978.45 | 983.69 | 899.77 | 861.94 | 914.34 | |
| Operating Expenses Qtr | 775.76 | 791.08 | 737.78 | 749.72 | 732.47 | 802.22 | 741.76 | 729.17 | 663.60 | 598.33 | 621.98 | |
| Operating Profit Qtr | 278.32 | 314.07 | 290.66 | 271.32 | 149.37 | 169.55 | 196.34 | 221.76 | 206.69 | 239.58 | 262.82 | |
| EBIDT Qtr Cr | 313.82 | 327.66 | 311.99 | 303.07 | 186.20 | 204.48 | 236.69 | 254.52 | 236.17 | 263.61 | 292.36 | |
| Depreciation Qtr | 34.25 | 34.26 | 33.71 | 33.18 | 33.02 | 33.30 | 32.70 | 31.78 | 31.16 | 31.72 | 31.54 | |
| Net Profit Qtr | 202.72 | 210.03 | 195.30 | 208.12 | 122.25 | 134.51 | 156.60 | 174.62 | 151.21 | 191.78 | 195.94 | |
| Basic EPS Qtr | 16.10 | 16.68 | 15.51 | 16.53 | 9.54 | 10.50 | 12.22 | 13.63 | 17.70 | 22.16 | 22.64 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 4293.31 | 3841.28 | 3456.67 | 2915.67 | 2680.06 | |
| Operating Expenses Annual Cr | 3036.77 | 2959.39 | 2411.69 | 1891.13 | 1904.54 | |
| Operating Profit Annual | 1171.94 | 783.25 | 929.30 | 998.56 | 683.33 | |
| Operating Profit Margin Annual % | 27.30 | 20.39 | 26.88 | 34.25 | 25.50 | |
| Total Expenses Annual Cr | 3179.38 | 3096.03 | 2547.19 | 2015.49 | 2012.17 | |
| EBIDT Annual Cr | 1256.54 | 881.89 | 1044.98 | 1024.54 | 775.52 | |
| EBIDT Annual margin % | 29.27 | 22.96 | 30.23 | 35.14 | 28.94 | |
| Depreciation | 135.40 | 130.80 | 125.30 | 116.09 | 95.72 | |
| PAT Before ExtraOrdinary Items Annual Cr | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 | |
| Net Profit Annual | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 | |
| Basic EPS Annual | 64.82 | 45.89 | 82.45 | 75.09 | 53.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3567.36 | 3387.99 | 3264.34 | 2995.63 | 2598.87 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 175.27 | 151.75 | 143.85 | 134.46 | 113.65 | |
| Total Current Liabilities Annual Cr | 895.76 | 1139.28 | 647.39 | 648.63 | 606.17 | |
| Total Capital Plus Liabilities Annual Cr | 4638.39 | 4679.02 | 4055.58 | 3778.72 | 3318.69 | |
| Fixed Assets Annual | 1735.64 | 1705.91 | 1664.85 | 1649.30 | 1604.00 | |
| Total Non Current Assets Annual | 1907.47 | 1845.02 | 1791.12 | 1751.13 | 1676.98 | |
| Total Current Assets Annual | 2730.92 | 2834.00 | 2264.46 | 2027.59 | 1641.71 | |
| Total Assets Annual | 4638.39 | 4679.02 | 4055.58 | 3778.72 | 3318.69 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 91.52 | 76.44 | 168.98 | 182.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 785.07 | 791.78 | 562.04 | 576.31 | 456.77 | |
| Cash from Investing Activity Annual | 65.39 | -559.60 | -74.10 | -282.39 | -224.41 | |
| Cash from Financing Annual Activity | -1051.06 | -107.87 | -460.04 | -318.29 | -128.63 | |
| Net Cash Flow Annual | - | 124.31 | 27.90 | -24.37 | 103.73 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 282.34 | 268.14 | 380.24 | 344.52 | 296.34 | |
| ROE Annual % | 22.87 | 17.35 | 21.83 | 21.82 | 17.99 | |
| ROCE Annual % | 29.95 | 21.21 | 26.98 | 29.02 | 25.06 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| EBDIT Annual Margin % | 29.85 | 23.56 | 31.27 | 35.45 | 29.96 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Kotak Small Cap Fund | 1.24 | 74518109 | - | - |
| Hdfc Large And Mid Cap Fund | 1.04 | 74518110 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Rajesh M Agrawal, trustee Rajesh Agrawal Trust | 14.48 | 74518095 | 0 | 0 |
| Yogesh M Agrawal, trustee Yogesh Agrawal Trust | 14.48 | 74518096 | 0 | 0 |
| Ravi P Agrawal, trustee Ravi Agrawal Trust | 13.01 | 74518097 | 32.85 | 0 |
| Aayush M Agrawal, trustee Aayush Agrawal Trust | 11.31 | 74518098 | 33.98 | 0 |
| Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal | 2.68 | 74518099 | 0 | 0 |
| Gabs Investments Pvt Ltd | 10 | 74518104 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Uti Flexi Cap Fund | 3.08 | 74518107 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 2.99 | 74518108 |
| Kotak Small Cap Fund | 1.24 | 74518109 |
| Hdfc Large And Mid Cap Fund | 1.04 | 74518110 |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | 1.65 | 74518112 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 08, 2024 | 26 | INTERIM | Feb 08, 2024 | Equity Share |
| Aug 04, 2023 | 10 | INTERIM | Aug 04, 2023 | Equity Share |
| Aug 04, 2023 | 15 | SPECIAL | Aug 04, 2023 | Equity Share |
| Nov 11, 2022 | 7 | INTERIM | Nov 14, 2022 | Equity Share |
| Nov 09, 2021 | 9.5 | INTERIM | Nov 10, 2021 | Equity Share |
| Nov 12, 2020 | 9.5 | INTERIM | Nov 13, 2020 | Equity Share |
| Nov 15, 2019 | 13 | INTERIM | Nov 18, 2019 | Equity Share |
| Nov 09, 2018 | 9 | INTERIM | Nov 12, 2018 | Equity Share |
| Mar 23, 2017 | 7 | INTERIM | Mar 25, 2017 | Equity Share |
| Nov 07, 2016 | 6 | INTERIM | Nov 08, 2016 | Equity Share |
| Mar 17, 2016 | 8 | INTERIM | Mar 19, 2016 | Equity Share |
| Jun 25, 2015 | 6 | FINAL | - | Equity Share |
| Jul 24, 2014 | 10 | FINAL | - | Equity Share |
| Jul 18, 2013 | 6.25 | FINAL | - | Equity Share |
| Jun 28, 2012 | 7.5 | FINAL | - | Equity Share |
| Jun 23, 2011 | 5 | FINAL | - | Equity Share |
| Jun 29, 2010 | 3.5 | FINAL | - | Equity Share |
| Jun 30, 2009 | 2.5 | FINAL | - | Equity Share |
| Jun 27, 2008 | 2.5 | FINAL | - | Equity Share |
| Sep 19, 2007 | 2 | FINAL | - | Equity Share |
| Sep 18, 2006 | 1.5 | FINAL | - | Equity Share |
| Dec 17, 2002 | - | FINAL | - | Equity Share |
| Sep 05, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Mar 20, 2015 | 5:2 | - |
| Aug 09, 2012 | 10:5 | 2012-08-10 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results & Buy Back of Shares | - |
| Jan 31, 2024 | Quarterly Results & 2nd Interim Dividend | - |
| Oct 31, 2023 | Quarterly Results | - |
| Jul 27, 2023 | Quarterly Results | - |
| May 05, 2023 | Audited Results | - |
| Mar 10, 2023 | Buy Back of shares | - |
| Feb 01, 2023 | Quarterly Results | - |
| Nov 03, 2022 | Quarterly Results & Interim Dividend | - |
| Jul 28, 2022 | Quarterly Results | - |
| May 10, 2022 | Audited Results & Bonus issue | - |
| Jan 31, 2022 | Quarterly Results | - |
| Dec 28, 2021 | Buy Back of Shares | - |
| Oct 29, 2021 | Quarterly Results & Interim Dividend | - |
| Jul 29, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results | - |
| Feb 02, 2021 | Quarterly Results | - |
| Nov 03, 2020 | Quarterly Results & Interim Dividend | Buy Back of Shares |
| Jul 30, 2020 | Quarterly Results | - |
| May 20, 2020 | Audited Results | - |
| Feb 05, 2020 | Quarterly Results | - |
| Nov 05, 2019 | Quarterly Results & Interim Dividend | - |
| Jul 31, 2019 | Quarterly Results | - |
| Apr 30, 2019 | Audited Results | - |
| Jan 30, 2019 | Quarterly Results & Buy Back of Shares | - |
| Oct 31, 2018 | Quarterly Results & Interim Dividend | - |
| Jul 31, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results | - |
| Jan 25, 2018 | Quarterly Results | - |
| Oct 31, 2017 | Quarterly Results | - |
| Aug 09, 2017 | Quarterly Results | - |
| May 03, 2017 | Audited Results | - |
| Mar 18, 2017 | Second Interim Dividend | - |
| Jan 24, 2017 | Quarterly Results | - |
| Oct 26, 2016 | Quarterly Results & Interim Dividend | - |
| Jul 26, 2016 | Quarterly Results | - |
| Apr 29, 2016 | Audited Results & Final Dividend | - |
| Mar 09, 2016 | Interim Dividend | - |
| Feb 01, 2016 | Quarterly Results | - |
| Oct 30, 2015 | Quarterly Results | - |
| Aug 13, 2015 | Quarterly Results | - |
| May 08, 2015 | Audited Results & Dividend | - |
| Jan 28, 2015 | Quarterly Results | - |
| Oct 30, 2014 | Quarterly Results | - |
| Aug 05, 2014 | Quarterly Results | - |
| Jun 13, 2014 | Appointments of Directors | To considering appointment of two Additional Directors of the company. |
| May 05, 2014 | Audited Results & Dividend | - |
| Jan 27, 2014 | Quarterly Results | - |
| Oct 28, 2013 | Quarterly Results | - |
| Jul 29, 2013 | Quarterly Results & Bonus issue | To consider Bonus issue of shares. |
| Apr 30, 2013 | Audited Results & Dividend | - |
| Jan 23, 2013 | Quarterly Results | - |
| Oct 25, 2012 | Quarterly Results | - |
| Jul 19, 2012 | Quarterly Results | - |
| Apr 26, 2012 | Audited Results, Dividend & Stock split | The Board the recommended Dividend @ Rs. 7.50 per Equity Share of the face value of Rs. 10/- each & approved sub-division of NV of Equity Shares of the Company from Rs. 10/- each to NV of Rs. 5/- each |
| Jan 24, 2012 | Quarterly Results | - |
| Oct 24, 2011 | Quarterly Results | - |
| Jul 28, 2011 | Quarterly Results | - |
| Apr 30, 2011 | Audited Results & Dividend | - |
| Jan 20, 2011 | Quarterly Results | - |
| Oct 22, 2010 | Quarterly Results | - |
| Jul 30, 2010 | Quarterly Results | - |
| May 06, 2010 | Audited Results & Dividend | - |
| Jan 29, 2010 | Quarterly Results | - |
| Oct 29, 2009 | Buy Back of Shares | The Board has approved buy back of Co's Shares through stock exchange for an amount of Rs. 11.36 crs. at a price not exceeding Rs. 101 per shares, subject to necessary applicable regulatory approvals. |
| Jul 30, 2009 | Quarterly Results | - |
| May 15, 2009 | Audited Results & Dividend | - |
| Jan 29, 2009 | Quarterly Results | - |
| Oct 23, 2008 | Quarterly Results | - |
| Jul 30, 2008 | Quarterly Results | - |
| Apr 30, 2008 | Audited Results & Dividend | - |
| Jan 30, 2008 | Quarterly Results | - |
| Oct 30, 2007 | Quarterly Results | - |
| Jul 30, 2007 | Quarterly Results | - |
| Apr 27, 2007 | Audited Results & Dividend | - |
| Jan 30, 2007 | Quarterly Results | - |
| Oct 30, 2006 | Quarterly Results | - |
| Apr 28, 2006 | Accounts & Dividend | - |
| Jan 27, 2006 | Quarterly Results | - |
| Oct 28, 2005 | Quarterly Results | - |
| Jul 30, 2005 | Quarterly Results | - |
| Apr 30, 2005 | Accounts | - |
| Jan 18, 2005 | Quarterly Results | - |
| Oct 29, 2004 | Quarterly Results | - |
| Jul 30, 2004 | Quarterly Results | - |
| May 22, 2004 | Accounts | - |
| Jan 10, 2004 | Quarterly Results | - |
| Oct 21, 2003 | Quarterly Results | - |
| Jul 26, 2003 | Quarterly Results | - |
| Jun 28, 2003 | Accounts | - |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 30, 2002 | Quarterly Results | - |
| Jul 29, 2002 | Quarterly Results | - |
| May 30, 2002 | Accounts & Dividend | - |
| Jan 28, 2002 | Quarterly Results | - |
| Oct 30, 2001 | Half Yearly Results | - |
| Jul 30, 2001 | Dividend & Quarterly Results | - |
| May 12, 2001 | Accounts | - |
| Jan 21, 2001 | Quarterly Results | - |
| Oct 21, 2000 | Half Yearly Results | - |
| Jul 15, 2000 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jun 22, 2022 | 1:2 | 2022-06-23 |
| Sep 17, 2013 | 1:2 | 2013-09-18 |
06 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares
Submission of Public Announcement pursuant to the provisions of the SEBI (Buy-back of Securities) Regulations 2018
06 May 2024
AJANTA PHARMA LTD. - 532331 - Submission Of Board Resolution For Buy Back Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015.
PFA Board Resolution for Buy Back
03 May 2024
AJANTA PHARMA LTD. - 532331 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In our intimation dated 2nd May 2024, under Regulation 30 of SEBI (LODR) Regulations, 2015, we had inadvertently intimated about change of Cost Auditor. PFA correct intimation for change in cost auditors.
03 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (LODR), PFA Newspaper Publication of Financial Results for the quarter and year ended 31st March 2024.
03 May 2024
Ajanta Pharma Q4 Results Review - Higher Opex Leads To Ebitda/Profit After Tax Miss: Motilal Oswal
Aims to consistently outperform the industry in branded generics.
02 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 2nd May 2024 at 4.30 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsAudio-Q4-FY2024.mp3
02 May 2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Ajanta Pharma Ltd.
Pharmaceuticals company Ajanta Pharma announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Revenue from operations at Rs 1,054 crore against Rs 882 crore; up 20%. EBITDA at Rs 278 crore against Rs 149 crore; up 86%; EBITDA at 26%. Profit after tax at Rs 203 crore against Rs 122 crore; up 66%; PAT at 19%. FY24 Financial Highlights: Revenue from operations at Rs 4,209 crore against Rs 3,743 crore; up 12%. EBITDA at Rs 1,172 crore against Rs 783 crore; up 50%; EBITDA at 28%. Profit after tax at Rs 816 crore against Rs 588 crore; up 39%; PAT at 19%. Cashflow from operations (CFO) was Rs 785 crore, EBITDA to CFO conversion of 67%. Free cashflow (FCF) was Rs 637 crore, FCF to PAT conversion of 78%. Result PDF
02 May 2024
AJANTA PHARMA LTD. - 532331 - Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015, Pls Find Enclosed Details For: 1. Appointment Of Cost Auditors 2. Vacancy Of Cost Auditors 3. Re-Appointment Of Secretarial Auditors 4. Re-Appointment Of Tax Auditors
Pls find enclosed details towards: 1. Appointment of Cost Auditors 2. Vacancy of Cost Auditors 3. Re-appointment of Secretarial Auditors 4. Re-appointment of Tax Auditors
02 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of SEBI (LODR), we hereby inform that at the Board Meeting held today, the Board approved appointment of following persons as Additional Non-Executive Independent Director subject to approval of members: 1. Mr. David Rasquinha 2. Mrs. Medha Joshi 3. Mr. Rajesh Dalal 4. Mrs. Simi Thapar
02 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
NRC in its meeting held today allotted 1000 shares. Pls find attached enclosure for more details.
